Zhongchao Inc. (ZCMD)
NASDAQ: ZCMD · IEX Real-Time Price · USD
1.450
+0.070 (5.07%)
At close: May 16, 2024, 3:29 PM
1.470
+0.020 (1.38%)
After-hours: May 16, 2024, 5:47 PM EDT
Zhongchao Revenue
In the year 2023, Zhongchao had annual revenue of $19.43M with 37.33% growth.
Revenue (ttm)
$19.43M
Revenue Growth
+37.33%
P/S Ratio
0.55
Revenue / Employee
$167,534
Employees
116
Market Cap
10.68M USD
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 19.43M | 5.28M | 37.33% |
| Dec 31, 2022 | 14.15M | -2.15M | -13.16% |
| Dec 31, 2021 | 16.30M | -1.69M | -9.41% |
| Dec 31, 2020 | 17.99M | 3.11M | 20.88% |
| Dec 31, 2019 | 14.88M | 2.02M | 15.68% |
| Dec 31, 2018 | 12.87M | 3.05M | 31.07% |
| Dec 31, 2017 | 9.82M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Guardion Health Sciences | 12.06M |
| Biotricity | 11.63M |
| Biomerica | 5.41M |
| Aeterna Zentaris | 4.50M |
| BioCardia | 477.00K |
| Notable Labs | 310.00K |
| Bionomics | 15.00K |
ZCMD News
- 2 months ago - Zhongchao Inc. Announces Successful Medication Assistance Services for Over 7,000 SLE Patients with Approximately 130,000 Units of Medications - PRNewsWire
- 2 months ago - Zhongchao Inc. Announces 1-for-10 Share Consolidation - PRNewsWire
- 5 months ago - Zhongchao Inc. Collaborates with a Public Health Foundation to Support Sustainable and Effective Cancer Treatments - PRNewsWire
- 7 months ago - Zhongchao Inc. Launches Breast Cancer Follow-up Visit and Health Management Patient Guide Program on Breast Cancer Awareness Day - PRNewsWire
- 8 months ago - Zhongchao Inc. Introduces PRO-Based Disease Management Model for Lung Cancer Patients - PRNewsWire
- 9 months ago - Zhongchao Inc. Announces Serving over 10,000 Breast Cancer Patients with Its Comprehensive Disease Management - PRNewsWire
- 11 months ago - Zhongchao Inc. Partners with Ximalaya to Launch the First Audio Course Series for Cancer Education - PRNewsWire
- 1 year ago - Zhongchao Inc. Launch Digital Online Education Platform for Common Diseases Clinical Diagnosis and Treatment - PRNewsWire